Winbest Venture Investment

Winbest Venture Capital, also known as Kaifeng Venture Capital, is a prominent Chinese venture capital firm specializing in early and growth-stage investments within the healthcare and technology sectors. Founded in 2009 and headquartered in Suzhou, the firm focuses on high-growth areas such as innovative drug development, medical devices, and molecular diagnostics. Winbest is recognized for its deep industry expertise and its role in nurturing several successful biotechnology companies, including CStone Pharmaceuticals and Ascentage Pharma. The firm manages multiple RMB and USD funds, leveraging a strategic network to support its portfolio companies through clinical development and market entry. By bridging the gap between scientific innovation and commercialization, Winbest plays a significant role in the expansion of China's life sciences ecosystem.